Rhelion Life Sciences Corp.

C$0.02As of Sun 8 Nov 2026, 12:00 UTC

CSE:RHELFinancials

Country Canada

PE (Fwd) •••

TSR 6Y CAGR (30.06%)

Div yield —

ROE (41.31%)

Security Brokers, Dealers, and Flotation Companies

Beta (5Y) 0.89

PE TTM —

TSR TTM (33.33%)

Mkt cap C$12.28M

ROIC (15.26%)

SE Grade™

Value

Quality

Moat

Consensus

Reference

$0.0254

27.06%

(48.14%)

Hold 2|0|6|9|7

TTM

FYE 31 Mar CAD

FY2017

FY2018

FY2019

FY2020

FY2021

FY2022

FY2023

FY2024

FY2025

FY2026

FY2027E

Trend

5Y

10Y

Peers

2.301

Revenue$M

3.371

3.465

3.447

3.511

3.636

3.719

3.799

3.800

3.817

3.874

2.539

1.27%

1.73%

12

13.40

Revenue growth%

28.26

26.56

24.41

26.67

26.78

25.49

26.47

27.06

29.73

31.07

11.43

27.06

26.73

29

5.36

Gross margin%

25.19

26.20

28.70

27.77

27.94

25.70

24.59

23.04

24.05

23.67

13.15

24.05

25.44

59

29.12

Operating margin%

13.73

12.34

13.88

14.77

14.08

15.45

14.17

14.72

17.49

18.05

24.08

15.45

14.45

5

26.23

Net margin%

19.88

17.18

17.32

15.59

18.42

20.37

19.65

17.57

17.67

17.81

26.05

17.81

17.74

46

6.468

P/E ratio (avg)x

37.10

43.12

43.23

45.87

45.88

46.51

45.77

54.88

63.88

73.53

15.72

54.88

45.87

89

12.38

EV/EBITx

23.72

27.03

27.82

32.52

37.72

43.00

46.68

53.68

51.80

54.05

19.16

51.80

40.36

52

12.92

FCF yield (avg)%

32.90

34.54

32.51

30.53

33.30

35.46

36.28

37.61

35.15

35.17

17.50

35.46

34.85

10

7.08

FCF margin%

14.39

12.72

12.68

10.53

10.59

12.62

10.58

9.55

8.02

8.54

16.03

9.55

10.59

84

0.781

FCF / Net incomex

1.594

1.723

1.843

1.820

1.734

1.696

1.879

1.950

2.252

2.586

1.673

1.950

1.832

33

22.24

ROIC%

18.43

21.30

19.40

17.12

17.28

17.74

16.98

18.18

15.89

18.22

12.11

17.74

17.96

35

10.72

Return on equity%

9.36

7.42

8.48

9.76

7.96

7.40

8.47

9.50

8.64

9.12

12.04

8.64

8.56

58

29.90

Return on assets%

13.69

12.23

13.68

15.82

13.67

14.49

16.29

18.56

19.97

18.03

11.15

18.03

15.16

72

—

EPS$

—

—

—

—

—

—

—

—

—

—

—

7.48%

7.24%

—

2.92

EPS growth%

5.87

8.48

6.38

4.73

4.94

6.39

7.01

5.36

4.72

2.83

15.07

5.36

5.61

94

—

Bookvalue per sh$

—

—

—

—

—

—

—

—

—

—

—

1.11%

(1.08%)

—

—

FCF per share$

—

—

—

—

—

—

—

—

—

—

—

(2.41%)

(0.95%)

—

—

Dividend per sh$

—

—

—

—

—

—

—

—

—

—

—

0.61%

4.23%

—

3.81

Div yield (avg)%

9.99

8.83

10.84

13.31

10.43

12.86

14.35

11.36

10.26

12.44

26.85

12.44

11.10

49

27.87

Payout ratio%

15.36

14.95

15.22

13.22

14.45

16.43

19.07

19.79

17.12

19.21

11.95

19.07

15.90

41

623.4

Shares (diluted)M

616.4

681.9

714.3

669.6

646.2

642.0

707.5

659.6

597.5

620.8

613.6

(0.80%)

(0.60%)

88

13.20

Buyback yield%

28.67

28.94

28.07

29.26

30.15

27.39

28.33

31.05

29.66

26.98

16.11

28.33

28.81

91

0.862

D/E ratiox

0.921

1.025

1.189

1.170

1.220

1.368

1.450

1.536

1.694

1.726

0.911

1.536

1.294

71

4.649

Enterprise value$M

4.799

4.756

5.212

6.100

6.112

6.217

6.647

6.762

7.902

8.523

2.881

6.88%

6.53%

77

4.561

LT debt$M

0.767

0.669

0.664

0.654

0.621

0.566

0.580

0.645

0.626

0.547

4.130

(2.51%)

(4.19%)

57

Peers (US$8.694M)

Cap (US$)

PE

Scotia Metals Corp.

8.025M

—

Inverite Insights Inc.

7.040M

—

HYLQ Strategy Corp.

6.819M

2.389x

Milgrey Finance and…

8.916M

—

Capital

TTM

5Y

10Y

Leveragex

0.648

0.833

0.726

EBIT/Intx

1.620

0.097

0.113

Own earn%

28.72

5.23

(3.21)

Sh yield%

17.01

40.25

40.08

Owners

Insiders/Inst%

8.31

32.16

Short interest%

4.96

SBC / revenue%

3.65

Record

10Y

Profitable years

10/10

Revenue growth years

10/10

EPS growth years

10/10

Dividend streakyrs

13

Op margin range%

12–18

$1 testx

−0.1

Incr. ROIC%

7

Growth vs revenue

Latest

Trend

10Y CAGR

Rel growth

Revenue

$3.874M

1.73%

1.00×

Cost of revenue

$1.834M

1.80%

1.01×

Operating expenses

$0.922M

1.78%

1.01×